Newsroom

LOS ANGELES--(BUSINESS WIRE)--Candlelight Vigil to Mark National Homeless Persons' Memorial Day. - Sun., Dec. 21st...

SAN FRANCISCO--(BUSINESS WIRE)--Relyance AI, the first AI-native data security platform that tracks dynamic data flows in real-time from source code to AI models, today released an AI Data Ultimatum public opinion survey of 1,017 U.S. consumers to quantify how holiday shopping behavior is impacted by brand management of personal data in AI systems. Findings reveal that Americans are entering the holidays stressed, skeptical, and more digitally exposed than ever – conditions that dramatically ra...

SAN DIEGO--(BUSINESS WIRE)--Jack in the Box (NASDAQ: JACK) is officially kicking off its 75th anniversary, launching a year-long celebration packed with throwback menu items, exclusive collectibles, craveable deals, and surprises designed to thank the fans who’ve been riding with Jack since 1951. For 75 years, Jack in the Box has done fast food differently; pioneering the drive-thru, serving burgers and tacos side by side, and building a cult following fueled by bold flavors and even bolder ide...

FEASTERVILLE, Pa.--(BUSINESS WIRE)--Joe Hand Promotions, the nation’s largest and most experienced distributor of premium live sports content to commercial establishments, is proud to announce two marquee recognitions that underscore the company’s leadership, innovation, and growing impact across the sports and media landscape. Last week, Joe Hand Jr., President of Joe Hand Promotions, was named one of the Philadelphia Business Journal’s 2025 Most Admired CEOs, honoring his visionary leadership...

HOUSTON--(BUSINESS WIRE)--ConocoPhillips will host a conference call webcast on Thursday, Feb. 5 to discuss fourth-quarter 2025 financial and operating results....

CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, announces today its financial calendar for 2026. Indicative financial calendar1 Events Dates 2025 Full-Year Results Tuesday March 31, 2026 (after market close) Annual General Meeting Tuesday June 16, 2026 2026 Half-Year Results Friday September 25, 2026 (bef...

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, annonce aujourd'hui son calendrier financier pour l’année 2026. 24 février 2026 Publication du chiffre d’affaires du 4ème trimestre 2025 21 avril 2026 Publication des résultats annuels 2025 12 mai 2026 Publication du chiffre...

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, today announced its financial calendar for 2026. February 24, 2026   Publication of revenue for Q4 2025 April 21, 2026   Publication of 2025 financial statements May 12, 2026   Publication of revenue for Q1 2026 June 3, 2026   Annual sharehold...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605 Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total brut (1) Total net (2) 30 novembre 2025 33 125 992 43 655 841 43 645 841 (1) Le nombre de droits de vote bruts (ou droits de vote “théoriques”) sert de base de calcul pour les franchissements de seuil. Conformément à l’article 223-11 du Règlement G...

NEW YORK--(BUSINESS WIRE)--The 43rd Barometer from Sermo, a fast, frictionless HCP social engagement platform and leader in healthcare insights, shows that pharma-led direct-to-patient (DTP) GLP-1 prescribing programs are transforming treatment access pathways. Yet findings from 953 surveyed GLP-1 prescribers reveal sharp divisions over how involved pharma should be in clinical evaluation and prescribing. DTP Models are Gaining Ground and Disrupting Traditional Care Awareness of pharma-led DTP...